Ankylosing Spondylitis life expectancy

The general life expectancy of patients with ankylosing spondylitis is not directly affected by the disease itself and is similar to that of the general population. However, if the condition is not effectively controlled and severe complications such as pulmonary fibrosis or renal amyloidosis develop, life expectancy may be shortened. The survival period for these complications varies depending on disease severity and treatment. For example, patients with mild pulmonary fibrosis who receive appropriate treatment may have a survival period of more than 20 years, while those with severe disease who do not receive effective treatment may survive only about one year. For patients with ankylosing spondylitis, early detection and active treatment can control disease progression, reduce complications, and maintain a life expectancy close to that of the general population. Healthy lifestyle habits and proper health management also contribute to longevity in patients. If any discomfort symptoms arise, timely medical consultation is recommended.